In situ nasal gel drug delivery: A novel approach for brain targeting through the mucosal membrane

Artificial Cells, Nanomedicine and Biotechnology

Volumn 44, Issue 4, 2016, Pages 1167-1176

  Kaur, Prabhjot ^a   Garg, Tarun ^a   Rath, Goutam ^a   Goyal, Amit K ^a  

^a ISF COLLEGE OF PHARMACY   (India)

Author keywords

Brain targeting; Controlled release; In situ gel system; Mucosal site; Nasal drug delivery

Indexed keywords

DRUG PRODUCTS;

BRAIN TARGETING; CONTROLLED RELEASE; MUCOSAL SITE; NASAL DRUG DELIVERY; SITU GELS;

CONTROLLED DRUG DELIVERY;

ENZYME INHIBITOR; PENETRATION ENHANCING AGENT; PRODRUG; GEL;

ARTICLE; BLOOD FLOW; BRAIN; CONTROLLED DRUG RELEASE; CROSS LINKING; DIFFUSION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STRUCTURE; ENZYMATIC DEGRADATION; ENZYME ACTIVITY; GEL; GELATION; LIPOPHILICITY; MOLECULAR WEIGHT; MUCOADHESION; MUCOSA; MUCUS; NASAL DRUG DELIVERY SYSTEM; OSMOLARITY; PARTITION COEFFICIENT; PH; PHYSICAL CHEMISTRY; PKA; POLYMERIZATION; VISCOSITY; ANIMAL; HUMAN; INTRANASAL DRUG ADMINISTRATION; METABOLISM; NOSE MUCOSA; PROCEDURES;

ADMINISTRATION, INTRANASAL; ANIMALS; BRAIN; DRUG DELIVERY SYSTEMS; GELS; HUMANS; NASAL ABSORPTION; NASAL MUCOSA;

EID: 84971449711     PISSN: 21691401     EISSN: 2169141X     Source Type: Journal    
DOI: 10.3109/21691401.2015.1012260     Document Type: Article

References (89)

1. M.I.Alam,, S.Beg,, A.Samad,, S.Baboota,, K.Kohli,, J.Ali,,. 2010. Strategy for effective brain drug delivery. Eur J Pharm Sci. 40: 385–403.
2. J.Ali,, M.Ali,, S.Baboota,, J.K.Sahani,, C.Ramassamy,, L.Dao,, Bhavna 2010. Potential of nanoparticulate drug delivery systems by intranasal administration. Curr Pharm Des. 16:1644–1653.
3. A.I.Arida,, M.M.Al-Tabakha,, H.A.Hamoury,. 2007. Improving the high variable bioavailability of griseofulvin by SEDDS. Chem Pharm Bull (Tokyo). 55:1713–1719.
4. S.Basu,, A.K.Bandyopadhyay,. 2010. Development and characterization of mucoadhesive in situ nasal gel of midazolam prepared with Ficus carica mucilage. AAPS PharmSciTech. 11:1223–1231.
5. S.Bird,, S.Derry,, R.A.Moore,. 2014. Zolmitriptan for acute migraine attacks in adults. Cochrane Database Syst Rev. 5:CD008616.
6. A.K.Burkoth,, K.S.Anseth,. 2000. A review of photocrosslinked polyanhydrides: in situ forming degradable networks. Biomaterials. 21:2395–2404.
7. S.L.Cao,, E.Chen,, Q.Z.Zhang,, X.G.Jiang,. 2007. A novel nasal delivery system of a Chinese traditional medicine, Radix Bupleuri, based on the concept of ion-activated in situ gel. Arch Pharm Res. 30:1014–1019.
8. S.L.Cao,, X.W.Ren,, Q.Z.Zhang,, E.Chen,, F.Xu,, J.Chen,,. 2009. In situ gel based on gellan gum as new carrier for nasal administration of mometasone furoate. Int J Pharm. 365:109–115.
9. J.Carlfors,, K.Edsman,, R.Petersson,, K.Jornving,. 1998. Rheological evaluation of Gelrite in situ gels for ophthalmic use. Eur J Pharm Sci. 6:113–119.
10. S.Chaudhary,, T.Garg,, R.S.Murthy,, G.Rath,, A.K.Goyal,. 2014. Recent approaches of lipid-based delivery system for lymphatic targeting via oral route. J Drug Target. 22:871–882.
11. E.Chen,, J.Chen,, S.L.Cao,, Q.Z.Zhang,, X.G.Jiang,. 2010. Preparation of nasal temperature-sensitive in situ gel of Radix Bupleuri and evaluation of the febrile response mechanism. Drug Dev Ind Pharm. 36:490–496.
12. K.Y.Cho,, T.W.Chung,, B.C.Kim,, M.K.Kim,, J.H.Lee,, W.R.Wee,, C.S.Cho,. 2003. Release of ciprofloxacin from poloxamer-graft-hyaluronic acid hydrogels in vitro. Int J Pharm. 260:83–91.
13. K.Doring,, C.Best,, F.Birklein,, H.H.Kramer,. 2014. Zolmitriptan inhibits neurogenic inflammation and pain during electrical stimulation in human skin. Eur J Pain.
14. A.N.Fisher,, L.Illum,, S.S.Davis,, E.H.Schacht,. 1992. Di-iodo-L-tyrosine-labelled dextrans as molecular size markers of nasal absorption in the rat. J Pharm Pharmacol. 44:550–554.
15. Gagandeep, T.Garg,, B.Malik,, G.Rath,, A.K.Goyal,. 2014. Development and characterization of nano-fiber patch for the treatment of glaucoma. Eur J Pharm Sci. 53:10–16.
16. T.Garg,. 2014. Current nanotechnological approaches for an effective delivery of bio-active drug molecules in the treatment of acne. Artif Cells Nanomed Biotechnol. 1–8.
17. T.Garg,, A.K.Goyal,. 2012. Iontophoresis: drug delivery system by applying an electrical potential across the skin. Drug Deliv Lett. 2:270–280.
18. T.Garg,, A.K.Goyal,. 2014a. Biomaterial-based scaffolds–current status and future directions. Expert Opin Drug Deliv. 11:767–789.
19. T.Garg,, A.K.Goyal,. 2014b. Liposomes: targeted and controlled delivery system. Drug Deliv Lette. 4:62–71.
20. T.Garg,, A.K.Goyal,. 2014c. Medicated chewing gum: patient compliance oral drug delivery system. Drug Deliv Lett. 4:72–78.
21. T.Garg,, A.K.Goyal,, S.Arora,, R.Murthy,. 2012a. Development, optimization & evaluation of porous chitosan scaffold formulation of gliclazide for the treatment of Type-2 diabetes mellitus. Drug Deliv Lett. 2:251–261.
22. T.Garg,, A.Kumar,, G.Rath,, A.K.Goyal,. 2014a. Gastroretentive drug delivery systems for therapeutic management of peptic ulcer. Crit Rev Ther Drug Carrier Syst. 31:531–557.
23. T.Garg,, G.Rath,, A.K.Goyal,. 2014b. Ancient and advanced approaches for the treatment of an inflammatory autoimmune disease-psoriasis. Crit Rev Ther Drug Carrier Syst. 31:331–364.
24. T.Garg,, G.Rath,, A.K.Goyal,. 2014c. Biomaterials-based nanofiber scaffold: targeted and controlled carrier for cell and drug delivery. J Drug Target. 1–20.
25. T.Garg,, G.Rath,, A.K.Goyal,. 2014d. Comprehensive review on additives of topical dosage forms for drug delivery. Drug Deliv.
26. T.Garg,, O.Singh,, S.Arora,, R.Murthy,. 2011a. Dendrimer—A novel scaffold for drug delivery. Int J Pharm Sci Rev Res. 7:211–220.
27. T.Garg,, O.Singh,, S.Arora,, R.Murthy,. 2011b. Patented microencapsulation techniques and its application. J Pharm Res. 4:2097–2102.
28. T.Garg,, O.Singh,, S.Arora,, R.Murthy,. 2012b. Scaffold: a novel carrier for cell and drug delivery. Crit Rev Ther Drug Carrier Syst. 29:1–63.
29. T.Garg,, S.Singh,, A.K.Goyal,. 2013. Stimuli-sensitive hydrogels: an excellent carrier for drug and cell delivery. Crit Rev Ther Drug Carrier Syst. 30:369–409.
30. E.Gavini,, A.B.Hegge,, G.Rassu,, V.Sanna,, C.Testa,, G.Pirisino,, J.Karlsen,, P.Giunchedi,. 2006. Nasal administration of carbamazepine using chitosan microspheres: in vitro/in vivo studies. Int J Pharm. 307:9–15.
31. A.K.Goyal,, G.Rath,, T.Garg,. 2013a. Nanotechnological approaches for genetic immunization. DNA RNA Nanobiotechnol Med Diagnos Treatment Dis. 67–120.
32. G.Goyal,, T.Garg,, B.Malik,, G.Chauhan,, G.Rath,, A.K.Goyal,. 2013b. Development and characterization of niosomal gel for topical delivery of benzoyl peroxide. Drug Deliv.
33. G.Goyal,, T.Garg,, G.Rath,, A.K.Goyal,. 2014a. Current nanotechnological strategies for an effective delivery of drugs in treatment of periodontal disease. Crit Rev Ther Drug Carrier Syst. 31:89–119.
34. G.Goyal,, T.Garg,, G.Rath,, A.K.Goyal,. 2014b. Current nanotechnological strategies for treating glaucoma. Crit Rev Ther Drug Carrier Syst. 31:365–405.
35. S.Haque,, S.Md,, M.I.Alam,, J.K.Sahni,, J.Ali,, S.Baboota,. 2012. Nanostructure-based drug delivery systems for brain targeting. Drug Dev Ind Pharm. 38:387–411.
36. D.Hoffler,, K.Nebe,, E.O.Wiethoff,. 1972. [Studies on the absorption of the combined administration of erythromycin and bromohexine hydrochloride]. Arzneimittelforschung. 22:97–100.
37. T.Hussain,, T.Garg,, A.K.Goyal,, G.Rath,. 2014. Biomedical applications of nanofiber scaffolds in tissue engineering. J Biomater Tissue Eng. 4:600–623.
38. A.Iguchi,, A.Matsuu,, K.Matsuyama,, Y.Hikasa,. 2014. The efficacy of artemisinin, artemether, and lumefantrine against Babesia gibsoni in vitro. Parasitol Int. 64:190–193.
39. L.Illum,. 2000. Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci. 11:1–18.
40. L.Illum,. 2003. Nasal drug delivery–possibilities, problems and solutions. J Control Release. 87:187–198.
41. L.Illum,. 2007. Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems? J Pharm Sci. 96:473–483.
42. H.S.Johal,, T.Garg,, G.Rath,, A.K.Goyal,. 2014. Advanced topical drug delivery system for the management of vaginal candidiasis. Drug Deliv. 1–14.
43. D.Joshi,, T.Garg,, A.K.Goyal,, G.Rath,. 2014a. Advanced drug delivery approaches against periodontitis. Drug Deliv. 1–15.
44. D.Joshi,, T.Garg,, A.K.Goyal,, G.Rath,. 2014b. Development and characterization of novel medicated nanofibers against periodontitis. Curr Drug Deliv.
45. V.Kalia,, T.Garg,, G.Rath,, A.K.Goyal,. 2014. Development and evaluation of a sublingual film of the antiemetic granisetron hydrochloride. Artif Cells Nanomed Biotechnol. 1–5.
46. M.Y.Kasirer,, C.Welsh,, J.Pan,, Y.Shifrin,, J.Belik,. 2014. Metoclopramide does not increase gastric muscle contractility in newborn rats. Am J Physiol Gastrointest Liver Physiol. 306:G439–44.
47. K.Kataria,, A.Sharma,, T.Garg,, A.K.Goyal,, G.Rath,. 2014. Novel technology to improve drug loading in polymeric nanofibers. Drug Deliv Lett. 4:79–86.
48. M.Kaur,, T.Garg,, R.K.Narang,. 2014a. A review of emerging trends in the treatment of tuberculosis. Artif Cells Nanomed Biotechnol. 1–7.
49. M.Kaur,, T.Garg,, G.Rath,, A.K.Goyal,. 2014b. Current nanotechnological strategies for effective delivery of bioactive drug molecules in the treatment of tuberculosis. Crit Rev Ther Drug Carrier Syst. 31:49–88.
50. M.Kaur,, B.Malik,, T.Garg,, G.Rath,, A.K.Goyal,. 2014c. Development and characterization of guar gum nanoparticles for oral immunization against tuberculosis. Drug Deliv.
51. N.Kaur,, T.Garg,, A.K.Goyal,, G.Rath,. 2014d. Formulation, optimization and evaluation of curcumin-beta-cyclodextrin-loaded sponge for effective drug delivery in thermal burns chemotherapy. Drug Deliv. 1–10.
52. P.Kaur,, T.Garg,, G.Rath,, R.S.Murthy,, A.K.Goyal,. 2014e. Development, optimization and evaluation of surfactant-based pulmonary nanolipid carrier system of paclitaxel for the management of drug resistance lung cancer using Box-Behnken design. Drug Deliv. 1–14.
53. P.Kaur,, T.Garg,, G.Rath,, R.S.Murthy,, A.K.Goyal,. 2014f. Surfactant-based drug delivery systems for treating drug-resistant lung cancer. Drug Deliv. 1–12.
54. P.Kaur,, T.Garg,, B.Vaidya,, A.Prakash,, G.Rath,, A.K.Goyal,. 2014g. Brain delivery of intranasal in situ gel of nanoparticulated polymeric carriers containing antidepressant drug: behavioral and biochemical assessment. J Drug Target. 1–12.
55. R.Kaur,, T.Garg,, U.Das Gupta,, P.Gupta,, G.Rath,, A.K.Goyal,. 2014h. Preparation and characterization of spray-dried inhalable powders containing nanoaggregates for pulmonary delivery of anti-tubercular drugs. Artif Cells Nanomed Biotechnol. 1–6.
56. R.Kaur,, T.Garg,, B.Malik,, U.D.Gupta,, P.Gupta,, G.Rath,, A.K.Goyal,. 2014i. Development and characterization of spray-dried porous nanoaggregates for pulmonary delivery of anti-tubercular drugs. Drug Deliv. 1–6.
57. R.Kaur,, T.Garg,, G.Rath,, A.K.Goyal,. 2014j. Advanced aerosol delivery devices for potential cure of acute and chronic diseases. Crit Rev Ther Drug Carrier Syst. 31:495–530.
58. V.Kaur,, T.Garg,, G.Rath,, A.K.Goyal,. 2014k. Therapeutic potential of nanocarrier for overcoming to P-glycoprotein. J Drug Target. 1–12.
59. N.Kawasaki,, R.Ohkura,, S.Miyazaki,, Y.Uno,, S.Sugimoto,, D.Attwood,. 1999. Thermally reversible xyloglucan gels as vehicles for oral drug delivery. Int J Pharm. 181:227–234.
60. R.M.Mainardes,, M.C.Urban,, P.O.Cinto,, M.V.Chaud,, R.C.Evangelista,, M.P.Gremiao,. 2006. Liposomes and micro/nanoparticles as colloidal carriers for nasal drug delivery. Curr Drug Deliv. 3: 275–285.
61. R.J.Majithiya,, P.K.Ghosh,, M.L.Umrethia,, R.S.Murthy,. 2006. Thermoreversible-mucoadhesive gel for nasal delivery of sumatriptan. AAPS PharmSciTech. 7:67.
62. R.Malik,, T.Garg,, A.K.Goyal,, G.Rath,. 2014. Polymeric nanofibers: targeted gastro-retentive drug delivery systems. J Drug Target. 1–16.
63. S.Mao,, J.Chen,, Z.Wei,, H.Liu,, D.Bi,. 2004. Intranasal administration of melatonin starch microspheres. Int J Pharm. 272:37–43.
64. H.Marwah,, T.Garg,, A.K.Goyal,, G.Rath,. 2014. Permeation enhancer strategies in transdermal drug delivery. Drug Deliv. 1–15.
65. V.Modgill,, T.Garg,, A.K.Goyal,, G.Rath,. 2014a. Permeability study of ciprofloxacin from ultra-thin nanofibrous film through various mucosal membranes. Artif Cells Nanomed Biotechnol. 1–6.
66. V.Modgill,, T.Garg,, A.K.Goyal,, G.Rath,. 2014b. Transmucosal Delivery of Linagliptin for the Treatment of Type- 2 Diabetes Mellitus by Ultra-Thin Nanofibers. Curr Drug Deliv.
67. A.Morie,, T.Garg,, A.K.Goyal,, G.Rath,. 2014. Nanofibers as novel drug carrier – an overview. Artif Cells Nanomed Biotechnol. 1–9.
68. S.Pabreja,, T.Garg,, G.Rath,, A.K.Goyal,. 2014. Mucosal vaccination against tuberculosis using Ag85A-loaded immunostimulating complexes. Artif Cells Nanomed Biotechnol. 1–8.
69. N.A.Peppas,, R.Langer,. 1994. New challenges in biomaterials. Science. 263:1715–1720.
70. K.Podual,, F.J.Doyle,, III, N.A.Peppas,. 2000. Dynamic behavior of glucose oxidase-containing microparticles of poly(ethylene glycol)-grafted cationic hydrogels in an environment of changing pH. Biomaterials. 21:1439–1450.
71. Y.Qiu,, K.Park,. 2001. Environment-sensitive hydrogels for drug delivery. Adv Drug Deliv Rev. 53:321–339.
72. R.Rohilla,, T.Garg,, J.Bariwal,, A.K.Goyal,, G.Rath,. 2014a. Development, optimization and characterization of glycyrrhetinic acid-chitosan nanoparticles of atorvastatin for liver targeting. Drug Deliv. 1–8.
73. R.Rohilla,, T.Garg,, A.K.Goyal,, G.Rath,. 2014b. Herbal and polymeric approaches for liver-targeting drug delivery: novel strategies and their significance. Drug Deliv. 1–17.
74. E.S.Ron,, L.E.Bromberg,. 1998. Temperature-responsive gels and thermogelling polymer matrices for protein and peptide delivery. Adv Drug Deliv Rev. 31:197–221.
75. E.Sam,, A.P.Jeanjean,, J.M.Maloteaux,, N.Verbeke,. 1995. Apomorphine pharmacokinetics in parkinsonism after intranasal and subcutaneous application. Eur J Drug Metab Pharmacokinet. 20:27–33.
76. A.Sharma,, T.Garg,, A.Aman,, K.Panchal,, R.Sharma,, S.Kumar,, T.Markandeywar,. 2014a. Nanogel-an advanced drug delivery tool: current and future. Artif Cells Nanomed Biotechnol. 1–13.
77. R.Sharma,, T.Garg,, A.K.Goyal,, G.Rath,. 2014b. Development, optimization and evaluation of polymeric electrospun nanofiber: A tool for local delivery of fluconazole for management of vaginal candidiasis. Artif Cells Nanomed Biotechnol. 1–8.
78. R.Sharma,, H.Singh,, M.Joshi,, A.Sharma,, T.Garg,, A.K.Goyal,, G.Rath,. 2014c. Recent advances in polymeric electrospun nanofibers for drug delivery. Crit Rev Ther Drug Carrier Syst. 31:187–217.
79. B.Singh,, T.Garg,, A.K.Goyal,, G.Rath,. 2014a. Recent advancements in the cardiovascular drug carriers. Artif Cells Nanomed Biotechnol. 1–10.
80. H.Singh,, R.Sharma,, M.Joshi,, T.Garg,, A.K.Goyal,, G.Rath,. 2014b. Transmucosal delivery of Docetaxel by mucoadhesive polymeric nanofibers. Artif Cells Nanomed Biotechnol.
81. K.Singh,, N.Arora,, T.Garg,. 2012. RFID: a trustable security tool in pharmaceutical industry. Am J Pharm Tech Res. 2:113–127.
82. O.Singh,, T.Garg,, G.Rath,, A.K.Goyal,. 2014c. Microbicides for the treatment of sexually transmitted HIV infections. J Pharm. 1–18.
83. R.M.Singh,, A.Kumar,, K.Pathak,. 2013. Thermally triggered mucoadhesive in situ gel of loratadine: beta-cyclodextrin complex for nasal delivery. AAPS PharmSciTech. 14:412–424.
84. R.J.Soane,, M.Frier,, A.C.Perkins,, N.S.Jones,, S.S.Davis,, L.Illum,. 1999. Evaluation of the clearance characteristics of bioadhesive systems in humans. Int J Pharm. 178:55–65.
85. S.Wang,, P.Chen,, L.Zhang,, C.Yang,, G.Zhai,. 2012. Formulation and evaluation of microemulsion-based in situ ion-sensitive gelling systems for intranasal administration of curcumin. J Drug Target. 20:831–840.
86. X.Wang,, N.Chi,, X.Tang,. 2008. Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting. Eur J Pharm Biopharm. 70:735–740.
87. G.Wei,, H.Xu,, P.T.Ding,, S.M.Li,, J.M.Zheng,. 2002. Thermosetting gels with modulated gelation temperature for ophthalmic use: the rheological and gamma scintigraphic studies. J Control Release. 83: 65–74.
88. T.F.Whayne, Jr. 2014. Carvedilol versus metoprolol, but which metoprolol? Effect on inappropriate cardioverter-defibrillator therapy. J Am Coll Cardiol. 63:1933.
89. R.Zhao,, L.Liu,, Y.Wang,, Z.Xiao,. 2014. Vinegar-baked Radix Bupleuri modulates the cell membrane constituents and inhibits the P-gp activity in rat hepatocytes. BMC Complement Altern Med. 14:357.